Phillip Frost - Dec 2, 2024 Form 4/A - Amendment Insider Report for Fluent, Inc. (FLNT)

Role
10%+ Owner
Signature
/s/ Phillip Frost, M.D., Individually
Stock symbol
FLNT
Transactions as of
Dec 2, 2024
Transactions value $
$1,499,676
Form type
4/A - Amendment
Date filed
12/6/2024, 12:10 PM
Date Of Original Report
Dec 4, 2024
Previous filing
Nov 29, 2024
Next filing
Dec 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLNT Pre-Funded Warrant Award $1.5M +648K $2.31 648K Dec 2, 2024 Common Stock 648K $0.00 Held by Frost Gamma Investments Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 4, 2024, the reporting person filed a Form 4 which inadvertently reported the transaction code as "P." The transaction code should have been reported as "A" for a grant, award or other acquisition pursuant to Rule 16b-3(d).
F2 The Pre-Funded Warrants will terminate when exercised in full.
F3 These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.